CoChat
Sign Up
Cited by 445Aging and Gerontology ResearchFrailty in Older AdultsGenetics, Aging, and Longevity in Model Organisms

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study

Open access
Puzianowska-Kuźnicka, Monika, Owczarz, Magdalena, Wieczorowska-Tobis, Katarzyna, Nadrowski, Pawel, Chudek, Jerzy, Slusarczyk, Przemyslaw, Skalska, Anna, Jonas, Marta, Franek, Edward, Mossakowska, Malgorzata·2016·Immunity & Ageing
DOI 10.1186/s12979-016-0076-xPMC PMC4891873
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: In the elderly, chronic low-grade inflammation (inflammaging) is a risk factor for the development of aging-related diseases and frailty. Using data from several thousand Eastern Europeans aged 65 years and older, we investigated whether the serum levels of two proinflammatory factors, interleukin-6 (IL-6) and C-reactive protein (CRP), were associated with physical and cognitive performance, and could predict mortality in successfully aging elderly. RESULTS: IL-6 and CRP levels systematically increased in an age-dependent manner in the entire study group (IL-6: n = 3496 individuals, p < 0.001 and CRP: n = 3632, p = 0.003), and in the subgroup of successfully aging individuals who had never been diagnosed with cardiovascular disease, myocardial infarction, stroke, type 2 diabetes, or cancer, and had a Mini Mental State Examination (MMSE) score ≥24 and a Katz Activities of Daily Living (ADL) score ≥5 (IL-6: n = 1258, p < 0.001 and CRP: n = 1312, p < 0.001). In the subgroup of individuals suffering from aging-related diseases/disability, only IL-6 increased with age (IL-6: n = 2238, p < 0.001 and CRP: n = 2320, p = 0.249). IL-6 and CRP levels were lower in successfully aging individuals than in the remaining study participants (both p < 0.001). Higher IL-6 and CRP levels were associated with poorer physical performance (lower ADL score) and poorer cognitive performance (lower MMSE score) (both p < 0.001). This association remained significant after adjusting for age, gender, BMI, lipids, estimated glomerular filtration rate, and smoking status. Longer survival was associated with lower concentrations of IL-6 and CRP not only in individuals with aging-related diseases/disability (HR = 1.063 per each pg/mL, 95 % CI: 1.052-1.074, p < 0.001 and HR = 1.020 per each mg/L, 95 % CI: 1.015-1.025, p < 0.001, respectively) but also in the successfully aging subgroup (HR = 1.163 per each pg/mL, 95 % CI: 1.128-1.199, p < 0.001 and HR = 1.074 per each mg/L, 95 % CI: 1.047-1.100, p < 0.001, respectively). These associations remained significant after adjusting for age, gender, BMI, lipids and smoking status. The Kaplan-Meier survival curves showed similar results (all p < 0.001). CONCLUSIONS: Both IL-6 and CRP levels were good predictors of physical and cognitive performance and the risk of mortality in both the entire elderly population and in successfully aging individuals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12979-016-0076-x

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Kaplan-Meier survival curves for the elderly population that was classified according to quartiles of IL-6 concentrations. a. In the successfully aging subgroup, the 1-year mortality rates were 1.0 % for the <1st quartile, 0.6 % for the 1st-2nd quartile, 4.1 % for the 2nd-3rd quartile, and 6.8 % for the >3rd quartile. The differences between the <1st quartile and all of the other quartiles were significant (all p < 0.001). b. In the subgroup of individuals who suffered from aging-related diseases/disability, the 1-year mortality rates were 2.9 % for the <1st quartile, 5.7 % for the 1st-2nd quartile, 10.0 % for the 2nd-3rd quartile, and 15.8 % for the >3rd quartile. The differences between the <1st quartile and all of the other quartiles were significant (all p < 0.001)
Fig. 1 Kaplan-Meier survival curves for the elderly population that was classified according to quartiles of IL-6 concentrations. a. In the successfully aging subgroup, the 1-year mortality rates were 1.0 % for the <1st quartile, 0.6 % for the 1st-2nd quartile, 4.1 % for the 2nd-3rd quartile, and 6.8 % for the >3rd quartile. The differences between the <1st quartile and all of the other quartiles were significant (all p < 0.001). b. In the subgroup of individuals who suffered from aging-related diseases/disability, the 1-year mortality rates were 2.9 % for the <1st quartile, 5.7 % for the 1st-2nd quartile, 10.0 % for the 2nd-3rd quartile, and 15.8 % for the >3rd quartile. The differences between the <1st quartile and all of the other quartiles were significant (all p < 0.001)CC BY · PubMed Central
Fig. 2 Kaplan-Meier survival curves for the elderly population that was classified according to CRP concentrations. a. In the successfully aging subgroup, the 1-year mortality rates were 1.6 % for ≤3 mg/L, 2.8 % for 3.1–10 mg/L, and 8.8 % for >10 mg/L. The differences between ≤3 mg/L and the other concentration ranges were significant (all p < 0.001). b. In the subgroup of individuals who suffered from aging-related diseases/disability, the 1-year mortality rates were 6.3 % for ≤3 mg/L, 10.3 % for 3.1–10 mg/L, and 19.2 % for >10 mg/L. The differences between ≤3 mg/L and other concentration ranges were significant (all p < 0.001)
Fig. 2 Kaplan-Meier survival curves for the elderly population that was classified according to CRP concentrations. a. In the successfully aging subgroup, the 1-year mortality rates were 1.6 % for ≤3 mg/L, 2.8 % for 3.1–10 mg/L, and 8.8 % for >10 mg/L. The differences between ≤3 mg/L and the other concentration ranges were significant (all p < 0.001). b. In the subgroup of individuals who suffered from aging-related diseases/disability, the 1-year mortality rates were 6.3 % for ≤3 mg/L, 10.3 % for 3.1–10 mg/L, and 19.2 % for >10 mg/L. The differences between ≤3 mg/L and other concentration ranges were significant (all p < 0.001)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

Sorted by citations

Items 301–400 of 445

Related

See all

Metadata

Authors
Puzianowska-Kuźnicka, M., Owczarz, M., Wieczorowska-Tobis, K., Nadrowski, P., Chudek, J., Slusarczyk, P., Skalska, A., Jonas, M., Franek, E., & Mossakowska, M.
Affiliations
  • International Institute of Molecular and Cell Biology (PL)
  • Medical University of Silesia (PL)
  • Jagiellonian University (PL)
  • Mossakowski Medical Research Institute, Polish Academy of Sciences (PL)
ORCID
Venue
Immunity & Ageing
Publisher
Springer Science and Business Media LLC
Published
2016-06-03
Volume
13
Issue
1
Pages
21-21
ISSN
1742-4933 (ISSN-L)
DOI
10.1186/s12979-016-0076-x
PMC
PMC4891873
OpenAlex
W2416122254
Cited by
445
References
64
Citations by year
2026: 27 · 2025: 53 · 2024: 61 · 2023: 63 · 2022: 62 · 2021: 55 · 2020: 41 · 2019: 28 · 2018: 32 · 2017: 19 · 2016: 4
FWCI
48.26
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Immunity & Ageing (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Jagiellonian University Repository (Jagiellonian University) (submittedVersion, cc-by-nc-nd)
  • Jagiellonian University Repository (Jagiellonian University) (submittedVersion, other-oa)
  • Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by-nc-nd)
Funders
Polish Ministry of Science and Higher Education (PBZ-MEiN-9/2/2006 – K143/P01/2007/1)
Topics
  • Social Sciences › Psychology › Developmental and Educational Psychology › Aging and Gerontology Research
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
interleukin-6, C-reactive protein, inflammaging, successful aging, mortality, older adults, physical performance, activities of daily living, cognitive performance, Mini-Mental State Examination, frailty, age-related diseases, Eastern Europe, aging biomarkers, cardiovascular disease, type 2 diabetes, cancer, smoking, glomerular filtration rate, body mass index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review